WEBVTT
1
00:00:00.000 --> 00:00:02.580
We take a digital-first approach,
2
00:00:02.580 --> 00:00:05.520
challenging ourselves to create products, capabilities,
3
00:00:05.520 --> 00:00:09.180
and insights that are positively disruptive
4
00:00:09.180 --> 00:00:10.772
or raise the standard of care.
5
00:00:10.772 --> 00:00:13.439
(lively music)
6
00:00:17.370 --> 00:00:20.280
I'm delighted to welcome Lidia Fonseca,
7
00:00:20.280 --> 00:00:21.870
Executive Vice President
8
00:00:21.870 --> 00:00:24.300
and Chief Digital and Technology Officer
9
00:00:24.300 --> 00:00:26.343
at Pfizer since 2019.
10
00:00:28.290 --> 00:00:31.170
Lidia, welcome, and thank you for joining me.
11
00:00:31.170 --> 00:00:34.320
Tell us about Pfizer's bold digital transformation
12
00:00:34.320 --> 00:00:35.580
a little more.
13
00:00:35.580 --> 00:00:36.720
First, we lead
14
00:00:36.720 --> 00:00:40.230
with the experience we're trying to create
15
00:00:40.230 --> 00:00:43.943
for patients, physicians, payers, regulators,
16
00:00:43.943 --> 00:00:46.110
and our own colleagues.
17
00:00:46.110 --> 00:00:49.440
Second, we take a digital-first approach,
18
00:00:49.440 --> 00:00:52.350
challenging ourselves to create products, capabilities,
19
00:00:52.350 --> 00:00:56.040
and insights that are positively disruptive
20
00:00:56.040 --> 00:00:58.560
or raise the standard of care.
21
00:00:58.560 --> 00:01:00.870
Third, we bring digital innovation
22
00:01:00.870 --> 00:01:04.560
across our entire value chain horizontally
23
00:01:04.560 --> 00:01:07.380
so that we can achieve maximum impact.
24
00:01:07.380 --> 00:01:09.690
We're driving end-to-end innovation
25
00:01:09.690 --> 00:01:12.720
with three strategic priorities in mind:
26
00:01:12.720 --> 00:01:15.090
to improve patient health outcomes,
27
00:01:15.090 --> 00:01:17.292
to bring medicines to patients faster,
28
00:01:17.292 --> 00:01:19.770
and fuel tomorrow's breakthrough therapies,
29
00:01:19.770 --> 00:01:22.320
starting with research and discovery,
30
00:01:22.320 --> 00:01:25.080
where supercomputing capabilities
31
00:01:25.080 --> 00:01:28.650
with AI and machine learning are helping our scientists
32
00:01:28.650 --> 00:01:32.550
accelerate compounds through discovery to development.
33
00:01:32.550 --> 00:01:35.280
We leverage virtual in silico screening,
34
00:01:35.280 --> 00:01:38.400
which refers to sophisticated computational modeling
35
00:01:38.400 --> 00:01:40.380
and simulation techniques
36
00:01:40.380 --> 00:01:43.350
that test molecular compounds in a virtual lab.
37
00:01:43.350 --> 00:01:48.350
This capability reduces computational times by 80 to 90%,
38
00:01:48.930 --> 00:01:51.870
quickly narrowing down to only those compounds
39
00:01:51.870 --> 00:01:54.930
with the highest chance of becoming the medicine we need.
40
00:01:54.930 --> 00:01:58.083
How do we leverage digital data and AI
41
00:01:59.106 --> 00:02:03.330
and how this program has accelerated your purpose
42
00:02:03.330 --> 00:02:06.000
and what the biggest wins are so far?
43
00:02:06.000 --> 00:02:09.570
We're also using generative AI modeling
44
00:02:09.570 --> 00:02:14.010
to design entirely new molecules with optimal activity,
45
00:02:14.010 --> 00:02:15.810
searching beyond known molecules
46
00:02:15.810 --> 00:02:19.080
to propose entirely new chemical structures.
47
00:02:19.080 --> 00:02:20.730
In clinical development,
48
00:02:20.730 --> 00:02:23.010
digital brings the trial to the participant
49
00:02:23.010 --> 00:02:24.690
through remote trials,
50
00:02:24.690 --> 00:02:27.810
helping boost recruitment, retention, and diversity
51
00:02:27.810 --> 00:02:31.020
while elevating the participant experience.
52
00:02:31.020 --> 00:02:34.140
AI and machine learning are enabling our teams
53
00:02:34.140 --> 00:02:35.760
to perform quality checks
54
00:02:35.760 --> 00:02:39.090
and analyze vast amounts of clinical trial data
55
00:02:39.090 --> 00:02:42.090
50% faster than prior methods.
56
00:02:42.090 --> 00:02:43.800
Over on the manufacturing front,
57
00:02:43.800 --> 00:02:46.635
our patent-pending Digital Operations Center
58
00:02:46.635 --> 00:02:50.670
provides an end-to-end view of manufacturing and supply.
59
00:02:50.670 --> 00:02:53.040
This allows the team to predict issues
60
00:02:53.040 --> 00:02:54.810
and adjust in real time
61
00:02:54.810 --> 00:02:57.663
and has yielded 20% increase in throughput.